Amgen, Inc. – Strategy, SWOT and Corporate Finance Report

Amgen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

Amgen, Inc., (Amgen or 'the company') is a developer, manufacturer and marketer of human therapeutics. The company develops products mainly in the areas of oncology/hematology, cardiovascular, neuroscience, bone health and inflammation. Its product portfolio includes Prolia(denosumab), XGEVA(denosumab), EVENITY (romosozumab), Repatha (evolocumab), Aimovig (erenumab), Aranesp (darbepoetin alfa), BLINCYTO (blinatumomab), KYPROLIS(carfilzomib), Vectibix (panitumumab), Sensipar/Mimpara (cinacalcet), and AMJEVITA (adalimumab-atto). Amgen sells its products through pharmaceutical wholesale distributors and through direct-to-consumer channels, including print, online media and television. The company has business presence across the US, Europe, Latin America, the Middle East and Asia-Pacific. The company is headquartered in Thousand Oaks, California, the US.

Scope

– Detailed information on Amgen, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting Amgen, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of Amgen, Inc. including a breakdown and examination of key business segments

– Intelligence on Amgen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about Amgen, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Amgen, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Amgen, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Amgen, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

Table of Contents

Amgen, Inc.: Company Overview

Amgen, Inc.: Overview and Key Facts

Amgen, Inc.: Overview

Amgen, Inc.: Key Facts

Amgen, Inc.: Key Employees

Amgen, Inc.: Key Employee Biographies

Amgen, Inc.: Major Products and Services

Amgen, Inc.: Company History

Amgen, Inc.: Management Statement

Amgen, Inc.: Locations and Subsidiaries

Amgen, Inc.: Key Competitors

Amgen, Inc.: Company Analysis

Amgen, Inc.: Business Description

Amgen, Inc.: SWOT Analysis

Amgen, Inc.: SWOT Overview

Amgen, Inc.: Strengths

Amgen, Inc.: Weaknesses

Amgen, Inc.: Opportunities

Amgen, Inc.: Threats

Amgen, Inc.: Corporate Financial Deals Activity

Amgen, Inc.: Financial Deals Overview

Amgen, Inc.: Targets and Partners

Amgen, Inc.: Top Deals 2015 - 2019YTD*

Amgen, Inc.: Advisors

Amgen, Inc.: Top Legal Advisors

Amgen, Inc.: Top Financial Advisors

Amgen, Inc.: Mergers and Acquisitions

Amgen, Inc.: Corporate Venturing

Amgen, Inc.: Capital Raising

Amgen, Inc.: Partnership

Amgen, Inc.: Divestments

Amgen, Inc.: Recent Developments

Amgen, Inc.: News and Events Summary

Amgen, Inc.: Business Expansion

Amgen, Inc.: Contracts

Amgen, Inc.: Financial Deals

Amgen, Inc.: Market Developments

Amgen, Inc.: Regulatory and Legal Events

Amgen, Inc.: Research & Development

Amgen, Inc.: Strategy and Operations

Appendix

Contact Us

Methodology

About MarketLine

List of Tables

List of Tables

Table 1: Amgen, Inc.: Key Facts

Table 2: Amgen, Inc.: Key Employees

Table 3: Amgen, Inc.: Company History

Table 4: Amgen, Inc.: Locations and Subsidiaries

Table 5: Amgen, Inc.: Key Competitors

Table 6: Amgen, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Table 7: Amgen, Inc.: M&A Activity by Geography (TTM*)

Table 8: Amgen, Inc.: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Table 9: Amgen, Inc.: M&A Average Deal Size – Value (US$m)

Table 10: Amgen, Inc.: Targets and Partners

Table 11: Amgen, Inc.: Top Deals 2015 – 2019YTD*

Table 12: Amgen, Inc.: Legal Advisor Ranking by Value (US$m)

Table 13: Amgen, Inc.: Financial Advisor Ranking by Value (US$m)

Table 14: Amgen, Inc.: M&A Volume and Value Trend (2015 – YTD*2019)

Table 15: Amgen, Inc.: M&A Activity by Geography (2015 – YTD*2019)

Table 16: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Table 17: Amgen, Inc.: Corporate Venturing by Geography (2015 – YTD*2019)

Table 18: Amgen, Inc.: Capital Raising Volume and Value Trend (2015 – YTD*2019)

Table 19: Amgen, Inc.: Capital Raising by Deal Type (2015 – YTD*2019)

Table 20: Amgen, Inc.: Partnership Volume and Value Trend (2015 – YTD*2019)

Table 21: Amgen, Inc.: Partnership Trend by Deal Type (2015 – YTD*2019)

Table 22: Amgen, Inc.: Divestments Volume and Value Trend (2015 – YTD*2019)

Table 23: Amgen, Inc.: News and Events Summary

Table 24: Amgen, Inc.: Business Expansion

Table 25: Amgen, Inc.: Contracts

Table 26: Amgen, Inc.: Financial Deals

Table 27: Amgen, Inc.: Market Developments

Table 28: Amgen, Inc.: Regulatory and Legal Events

Table 29: Amgen, Inc.: Research & Development

Table 30: Amgen, Inc.: Strategy and Operations

List of Figures

List of Figures

Figure 1: Amgen, Inc.: Deal Activity by Deal Type – Volume (TTM*)

Figure 2: Amgen, Inc.: M&A Activity by Geography (TTM*)

Figure 3: Amgen, Inc.: Deal Activity by Deal Type – Volume (2015 – YTD*2019)

Figure 4: Amgen, Inc.: M&A Average Deal Size – Value (US$m)

Figure 5: Amgen, Inc.: M&A Volume and Value Trend (2015 – YTD*2019)

Figure 6: Amgen, Inc.: M&A Activity by Geography (2015 – YTD*2019)

Figure 7: Amgen, Inc.: Corporate Venturing Volume and Value Trend (2015 – YTD*2019)

Figure 8: Amgen, Inc.: Corporate Venturing by Geography (2015 – YTD*2019)

Figure 9: Amgen, Inc.: Capital Raising Volume and Value Trend (2015 – YTD*2019)

Figure 10: Amgen, Inc.: Capital Raising by Deal Type (2015 – YTD*2019)

Figure 11: Amgen, Inc.: Partnership Volume and Value Trend (2015 – YTD*2019)

Figure 12: Amgen, Inc.: Partnership Trend by Deal Type (2015 – YTD*2019)

Figure 13: Amgen, Inc.: Divestments Volume and Value Trend (2015 – YTD*2019)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports